表紙
市場調查報告書

膀胱癌:全球臨床實驗趨勢

Bladder Cancer Global Clinical Trials Review, H2, 2019

出版商 GlobalData 商品編碼 212840
出版日期 內容資訊 英文 908 Pages
訂單完成後即時交付
價格
Back to Top
膀胱癌:全球臨床實驗趨勢 Bladder Cancer Global Clinical Trials Review, H2, 2019
出版日期: 2019年12月12日內容資訊: 英文 908 Pages
簡介

本報告提供全球膀胱癌治療藥的臨床試驗資料,提供您各國的趨勢,臨床試驗數,潛力治療藥物,及主要企業和研究機關的臨床試驗狀況。

目錄

簡介

  • 膀胱癌
  • 報告指南

臨床試驗 各地區

  • 臨床試驗 各國
    • 對臨床實驗有所貢獻的前五國 - 亞太地區
    • 對臨床實驗有所貢獻的前五國 - 歐洲
    • 對臨床實驗有所貢獻的前幾名國家 - 北美
    • 對臨床實驗有所貢獻的前幾名國家 - 中東及非洲
    • 對臨床實驗有所貢獻的前幾名國家 - 中南美

臨床試驗:G7 各國

臨床試驗:G7 各國 各臨床實驗狀態

臨床試驗:E7 各國

臨床試驗:E7 各國 各臨床實驗狀態

臨床試驗 各Phase

  • 進行中的臨床實驗 各Phase

臨床試驗 各臨床實驗狀態

未完成的臨床實驗

每段時期的實驗人數

有力的贊助商

參與臨床實驗的主要企業

潛力治療藥物

臨床試驗 簡介

  • 臨床試驗概要: 前幾名企業
    • GlaxoSmithKline plc
    • Eli Lilly and Company
    • Pfizer Inc.
    • Spectrum Pharmaceuticals, Inc.
    • Sanofi
    • Merck & Co., Inc.
    • Bayer AG
    • F. Hoffmann-La Roche Ltd.
    • Endo Health Solutions Inc.
    • Bristol-Myers Squibb Company
  • 臨床試驗概要: 最高級大學 / 研究機關 / 醫院
    • National Cancer Institute
    • Memorial Sloan Kettering Cancer Center
    • European Organization for Research and Treatment of Cancer
    • The University of Texas M. D. Anderson Cancer Center
    • National Bladder Cancer Collaborative Group
    • Southwest Oncology Group
    • Medical Research Council Clinical Trials Unit
    • University of Michigan
    • Eastern Cooperative Oncology Group
    • Medical Research Council

5個主要的臨床試驗簡介

附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC5191CTIDB

GlobalData's clinical trial report, "Bladder Cancer Global Clinical Trials Review, H2, 2019" provides an overview of Bladder Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Bladder Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

  • List of Tables 4
  • List of Figures 5
  • Report Guidance 6
  • GlobalData Clinical Trials Report Coverage 7
  • Clinical Trials by Region 8
  • Clinical Trials and Average Enrollment by Country 9
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12
  • Top Five Countries Contributing to Clinical Trials in Europe 13
  • Top Countries Contributing to Clinical Trials in North America 14
  • Top Five Countries Contributing to Clinical Trials in Middle East and Africa 15
  • Top Five Countries Contributing to Clinical Trials in Central and South America 16
  • Clinical Trials by G7 Countries: Proportion of Bladder Cancer to Oncology Clinical Trials 17
  • Clinical Trials by Phase in G7 Countries 18
  • Clinical Trials in G7 Countries by Trial Status 19
  • Clinical Trials by E7 Countries: Proportion of Bladder Cancer to Oncology Clinical Trials 21
  • Clinical Trials by Phase in E7 Countries 22
  • Clinical Trials in E7 Countries by Trial Status 23
  • Clinical Trials by Phase 25
  • In Progress Trials by Phase 26
  • Clinical Trials by Trial Status 28
  • Clinical Trials by End Point Status 30
  • Subjects Recruited Over a Period of Time 32
  • Clinical Trials by Sponsor Type 34
  • Prominent Sponsors 35
  • Top Companies Participating in Bladder Cancer Therapeutics Clinical Trials 37
  • Prominent Drugs 39
  • Latest Clinical Trials News on Bladder Cancer 40
  • Nov 08, 2019: Neon Therapeutics announces updated data presented at Society for Immunotherapy of Cancer (SITC) Annual Meeting 40
  • Oct 21, 2019: Bavarian Nordic reports Phase II bladder cancer trial data 40
  • Oct 01, 2019: Roche's Tecentriq performs well in untreated bladder cancer 41
  • Sep 28, 2019: Seattle Genetics and Astellas announce results from phase 1 trial of investigational agent Enfortumab Vedotin in combination with immune therapy Pembrolizumab as first-line treatment for advanced Bladder Cancer 41
  • Sep 24, 2019: Constellation Pharmaceuticals advances CPI-0209 into Clinical Trials, expanding its EZH2 franchise 42
  • Sep 23, 2019: Roche to present new data from Tecentriq at the European Society for Medical Oncology 2019 Congress 42
  • Clinical Trial Profile Snapshots 44

Appendix 929

  • Abbreviations 929
  • Definitions 929
  • Research Methodology 930
  • Secondary Research 930
  • About GlobalData 931
  • Contact Us 931
  • Disclaimer 931
  • Source 932

List of Tables

  • Bladder Cancer Therapeutics, Global, Clinical Trials by Region, 2019* 8
  • Bladder Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019* 10
  • Bladder Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019* 11
  • Bladder Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2019* 12
  • Bladder Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2019* 13
  • Bladder Cancer Therapeutics Clinical Trials, North America, Top Countries, 2019* 14
  • Bladder Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2019* 15
  • Bladder Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2019* 16
  • Proportion of Bladder Cancer to Oncology Clinical Trials, G7 Countries (%), 2019* 17
  • Bladder Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2019* 18
  • Bladder Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019* 20
  • Proportion of Bladder Cancer to Oncology Clinical Trials, E7 Countries (%), 2019* 21
  • Bladder Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2019* 22
  • Bladder Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019* 24
  • Bladder Cancer Therapeutics, Global, Clinical Trials by Phase, 2019* 25
  • Bladder Cancer Therapeutics, Global, Clinical Trials In Progress by Phase 2019* 27
  • Bladder Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2019* 29
  • Bladder Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2019* 31
  • Bladder Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018 33
  • Bladder Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2019* 34
  • Bladder Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2019* 36
  • Bladder Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019* 38
  • Bladder Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019* 39

List of Figures

  • Bladder Cancer Therapeutics, Global, Clinical Trials by Region (%), 2019* 8
  • Bladder Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019* 9
  • Bladder Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019* 11
  • Bladder Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2019* 12
  • Bladder Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2019* 13
  • Bladder Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2019* 14
  • Bladder Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2019* 15
  • Bladder Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2019* 16
  • Proportion of Bladder Cancer to Oncology Clinical Trials, G7 Countries (%), 2019* 17
  • Bladder Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2019* 18
  • Bladder Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019* 19
  • Proportion of Bladder Cancer to Oncology Clinical Trials, E7 Countries (%), 2019* 21
  • Bladder Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2019* 22
  • Bladder Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019* 23
  • Bladder Cancer Therapeutics, Global, Clinical Trials by Phase (%), 2019* 25
  • Bladder Cancer Therapeutics, Global, Clinical Trials In Progress by Phase, 2019* 26
  • Bladder Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2019* 28
  • Bladder Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2019* 30
  • Bladder Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018 32
  • Bladder Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2019* 34
  • Bladder Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2019* 35
  • Bladder Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019* 37
  • Bladder Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019* 39
  • GlobalData Methodology 930
Back to Top